Inferring school district learning modalities during the COVID-19 pandemic with a hidden Markov model.

Autor: Mark J Panaggio, Mike Fang, Hyunseung Bang, Paige A Armstrong, Alison M Binder, Julian E Grass, Jake Magid, Marc Papazian, Carrie K Shapiro-Mendoza, Sharyn E Parks

Publikováno v: PLoS ONE, Vol 18, Iss 10, p e0292354 (2023)

During the COVID-19 pandemic, many public schools across the United States shifted from fully in-person learning to alternative learning modalities such as hybrid and fully remote learning. In this study, data from 14,688 unique school districts from

Externí odkaz: https://doaj.org/article/6b1a5a0721d54ee999ba27e5bfc8d111

Hepatitis C virus attributable liver cancer in the country of Georgia, 2015–2019: a case–control study

Autor: Sophia Surguladze, Paige A. Armstrong, Geoff A. Beckett, Shaun Shadaker, Amiran Gamkrelidze, Maia Tsereteli, Vladimer Getia, Benedict Oppong Asamoah

Publikováno v: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-11 (2024)

Abstract Background Hepatitis C virus (HCV) infection can lead to a type of primary liver cancer called hepatocellular carcinoma (HCC). Georgia, a high HCV prevalence country, started an HCV elimination program in 2015. In addition to tracking incide

Externí odkaz: https://doaj.org/article/f63a489542d946a98a09cdd18dec5663

Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016

Autor: Paige A. Armstrong, Sandra M. Rivera, Patricia Escandon, Diego H. Caceres, Nancy Chow, Matthew J. Stuckey, Jorge Díaz, Adriana Gomez, Norida Vélez, Andres Espinosa-Bode, Soraya Salcedo, Adriana Marin, Indira Berrio, Carmen Varón, Angel Guzman, Jairo E. Pérez-Franco, Julian D. Escobar, Nohora Villalobos, Juan M. Correa, Anastasia P. Litvintseva, Shawn R. Lockhart, Ryan Fagan, Tom M. Chiller, Brendan Jackson, Oscar Pacheco

Publikováno v: Emerging Infectious Diseases, Vol 25, Iss 7, Pp 1339-1346 (2019)

Candida auris is an emerging multidrug-resistant fungus that causes hospital-associated outbreaks of invasive infections with high death rates. During 2015–2016, health authorities in Colombia detected an outbreak of C. auris. We conducted an inves

Externí odkaz: https://doaj.org/article/65bcf8cdef3c4ed6a6d3bd3a96363730

Multistate Epidemiology of Histoplasmosis, United States, 2011–2014

Autor: Paige A. Armstrong, Brendan R. Jackson, Dirk Haselow, Virgie Fields, Malia Ireland, Connie Austin, Kimberly Signs, Veronica Fialkowski, Reema Patel, Peggy Ellis, Peter C. Iwen, Caitlin Pedati, Suzanne Gibbons-Burgener, Jannifer Anderson, Thomas Dobbs, Sherri Davidson, Mary McIntyre, Kimberly Warren, Joanne Midla, Nhiem Luong, Kaitlin Benedict

Publikováno v: Emerging Infectious Diseases, Vol 24, Iss 3, Pp 425-431 (2018)

Histoplasmosis is one of the most common mycoses endemic to the United States, but it was reportable in only 10 states during 2016, when a national case definition was approved. To better characterize the epidemiologic features of histoplasmosis, we

Externí odkaz: https://doaj.org/article/dc9445c6a56545b8b1046522be081264

Economic evaluation of the Hepatitis C virus elimination program in the country of Georgia, 2015 to 2017

Autor: Irina Tskhomelidze, Shaun Shadaker, Tinatin Kuchuloria, Lia Gvinjilia, Maia Butsashvili, Muazzam Nasrullah, Tamar Gabunia, Amiran Gamkrelidze, Vladimer Getia, Lali Sharvadze, Tengiz Tsertsvadze, Jaba Zarqua, Shota Tsanava, Senad Handanagic, Paige A. Armstrong, Francisco Averhoff, Peter Vickerman, Josephine G. Walker

Publikováno v: Tskhomelidze, I, Shadaker, S, Kuchuloria, T, Gvinjilia, L, Butsashvili, M, Nasrullah, M, Gabunia, T, Gamkrelidze, A, Getia, V, Sharvadze, L, Tsertsvadze, T, Zarqua, J, Tsanava, S, Handanagic, S, Armstrong, P A, Averhoff, F, Vickerman, P T & Walker, J G 2022, ' Economic Evaluation of the Hepatitis C Virus Elimination Program in the Country of Georgia, 2015 to 2017 ', Liver International, pp. 1-11 . https://doi.org/10.1111/liv.15431

Background and AimsIn 2015, the country of Georgia launched an elimination program aiming to reduce the prevalence of Hepatitis C virus (HCV) infection by 90% from 5.4% prevalence (~150 000 people). During the first 2.5 years of the program, 770 832

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0bf56170a98594bb8d23b13786cb6f
https://doi.org/10.1111/liv.15431